Annual Working Capital
$28.88 M
-$83.71 M-74.35%
December 31, 2023
Summary
- As of February 12, 2025, TNXP annual working capital is $28.88 million, with the most recent change of -$83.71 million (-74.35%) on December 31, 2023.
- During the last 3 years, TNXP annual working capital has fallen by -$49.29 million (-63.05%).
- TNXP annual working capital is now -82.74% below its all-time high of $167.33 million, reached on December 31, 2021.
Performance
TNXP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$35.36 M
+$32.12 M+990.07%
September 30, 2024
Summary
- As of February 12, 2025, TNXP quarterly working capital is $35.36 million, with the most recent change of +$32.12 million (+990.07%) on September 30, 2024.
- Over the past year, TNXP quarterly working capital has stayed the same.
- TNXP quarterly working capital is now -80.68% below its all-time high of $183.06 million, reached on September 30, 2021.
Performance
TNXP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TNXP Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -74.3% | 0.0% |
| 3 y3 years | -63.0% | 0.0% |
| 5 y5 years | +23.4% | 0.0% |
TNXP Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.7% | at low | -79.9% | +990.1% |
| 5 y | 5-year | -82.7% | +227.7% | -80.7% | +990.1% |
| alltime | all time | -82.7% | +3795.0% | -80.7% | +1746.0% |
Tonix Pharmaceuticals Holding Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $35.36 M(+990.1%) |
| Jun 2024 | - | $3.24 M(-66.3%) |
| Mar 2024 | - | $9.62 M(-66.7%) |
| Dec 2023 | $28.88 M(-74.3%) | $28.88 M(+112.3%) |
| Sep 2023 | - | $13.60 M(-58.6%) |
| Jun 2023 | - | $32.89 M(-53.5%) |
| Mar 2023 | - | $70.65 M(-37.3%) |
| Dec 2022 | $112.60 M(-32.7%) | $112.60 M(-18.3%) |
| Sep 2022 | - | $137.80 M(-21.6%) |
| Jun 2022 | - | $175.84 M(+27.8%) |
| Mar 2022 | - | $137.63 M(-17.7%) |
| Dec 2021 | $167.33 M(+114.1%) | $167.33 M(-8.6%) |
| Sep 2021 | - | $183.06 M(+8.2%) |
| Jun 2021 | - | $169.19 M(+1.2%) |
| Mar 2021 | - | $167.14 M(+113.8%) |
| Dec 2020 | $78.17 M(+787.0%) | $78.17 M(+35.6%) |
| Sep 2020 | - | $57.64 M(+8.9%) |
| Jun 2020 | - | $52.95 M(+72.3%) |
| Mar 2020 | - | $30.74 M(+248.8%) |
| Dec 2019 | $8.81 M(-62.3%) | $8.81 M(-4.1%) |
| Sep 2019 | - | $9.19 M(-24.1%) |
| Jun 2019 | - | $12.11 M(-29.5%) |
| Mar 2019 | - | $17.17 M(-26.6%) |
| Dec 2018 | $23.40 M(-3.8%) | $23.40 M(+72.9%) |
| Sep 2018 | - | $13.53 M(-13.5%) |
| Jun 2018 | - | $15.65 M(-14.6%) |
| Mar 2018 | - | $18.32 M(-24.7%) |
| Dec 2017 | $24.32 M(-2.8%) | $24.32 M(-14.3%) |
| Sep 2017 | - | $28.37 M(-15.7%) |
| Jun 2017 | - | $33.66 M(+55.4%) |
| Mar 2017 | - | $21.65 M(-13.5%) |
| Dec 2016 | $25.02 M | $25.02 M(-5.9%) |
| Sep 2016 | - | $26.60 M(-9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $29.46 M(+10.2%) |
| Mar 2016 | - | $26.74 M(-32.7%) |
| Dec 2015 | $39.71 M(+11.4%) | $39.71 M(-23.8%) |
| Sep 2015 | - | $52.09 M(+14.0%) |
| Jun 2015 | - | $45.70 M(-19.1%) |
| Mar 2015 | - | $56.47 M(+58.4%) |
| Dec 2014 | $35.65 M(+455.4%) | $35.65 M(-17.9%) |
| Sep 2014 | - | $43.43 M(+2.3%) |
| Jun 2014 | - | $42.45 M(-11.3%) |
| Mar 2014 | - | $47.83 M(+645.0%) |
| Dec 2013 | $6.42 M(+636.2%) | $6.42 M(+20.1%) |
| Sep 2013 | - | $5.35 M(-348.9%) |
| Jun 2013 | - | -$2.15 M(+196.2%) |
| Mar 2013 | - | -$725.40 K(-183.2%) |
| Dec 2012 | $872.00 K(-211.6%) | $872.00 K(-215.0%) |
| Sep 2012 | - | -$758.10 K(-220.4%) |
| Jun 2012 | - | $629.50 K(-72.4%) |
| Mar 2012 | - | $2.28 M(-391.8%) |
| Dec 2011 | -$781.70 K(+210.7%) | -$781.70 K(+5111.3%) |
| Sep 2011 | - | -$15.00 K(+17.2%) |
| Jun 2011 | - | -$12.80 K(+14.3%) |
| Mar 2011 | - | -$11.20 K(-95.5%) |
| Dec 2010 | -$251.60 K(-2196.7%) | -$251.60 K(<-9900.0%) |
| Sep 2010 | - | $200.00(-94.7%) |
| Jun 2010 | - | $3800.00(-38.7%) |
| Mar 2010 | - | $6200.00(-48.3%) |
| Dec 2009 | $12.00 K(-72.0%) | $12.00 K(-22.6%) |
| Sep 2009 | - | $15.50 K(-14.4%) |
| Jun 2009 | - | $18.10 K(-43.4%) |
| Mar 2009 | - | $32.00 K(-25.4%) |
| Dec 2008 | $42.90 K | $42.90 K(-1200.0%) |
| Sep 2008 | - | -$3900.00(+1200.0%) |
| Jun 2008 | - | -$300.00(-106.0%) |
| Mar 2008 | - | $5000.00 |
FAQ
- What is Tonix Pharmaceuticals Holding annual working capital?
- What is the all time high annual working capital for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual working capital year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly working capital?
- What is the all time high quarterly working capital for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly working capital year-on-year change?
What is Tonix Pharmaceuticals Holding annual working capital?
The current annual working capital of TNXP is $28.88 M
What is the all time high annual working capital for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual working capital is $167.33 M
What is Tonix Pharmaceuticals Holding annual working capital year-on-year change?
Over the past year, TNXP annual working capital has changed by -$83.71 M (-74.35%)
What is Tonix Pharmaceuticals Holding quarterly working capital?
The current quarterly working capital of TNXP is $35.36 M
What is the all time high quarterly working capital for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly working capital is $183.06 M
What is Tonix Pharmaceuticals Holding quarterly working capital year-on-year change?
Over the past year, TNXP quarterly working capital has changed by $0.00 (0.00%)